Cervical cancer rates reduced by 87% in women vaccinated against HPV

 

https://www.eurekalert.org/news-releases/933965

 

 News Release 3-Nov-2021
Peer-Reviewed Publication
The Lancet

 

Cervical cancer rates are 87% lower in women who were offered vaccination against human papillomavirus (HPV) when they were between the ages of 12-13 than in previous generations confirms a new study published in The Lancet.

The researchers also found reductions in cervical cancer rates of 62% in women offered vaccination between the ages of 14-16, and 34% in women aged of 16-18 when vaccination was introduced. This is the first direct evidence of prevention of cervical cancer using the bivalent vaccine, Cervarix.
 

-----